THE LATEST

Grabar Law Office Files Suit on Behalf of The City of Charlotte Against Major Insulin Manufacturers and PBMs

By Grabar Law | Dec 16, 2025

Grabar Law Office and Hausfeld LLP today announced the filing of a major federal lawsuit in the U.S. District Court ...

Grabar Law Office In The News: Fiber Optics Co. Agrees To Reforms To End Derivative Suit

By Grabar Law | Nov 2, 2025

Fiber optic equipment company Luna Innovations Inc. has reached a deal with its investors to settle their derivative claims alleging ...

Grabar Law Office In the News: Alto Neuroscience Execs Sued Over Rosy Drug Claims

By Grabar Law | Oct 9, 2025

An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...

Grabar Law Office In the News: Marijuana Vape Antitrust Actions Consolidated In Calif.

By Grabar Law | Oct 9, 2025

Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...

Grabar Law Office In the News: DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe

By Grabar Law | Oct 9, 2025

The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania

By Grabar Law | Jul 11, 2025

Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...

Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims

By Grabar Law | Apr 19, 2025

A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...

Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors

By Grabar Law | Apr 19, 2025

Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...

GRABAR LAW OFFICE IN THE NEWS: NY BANK INVESTORS SPAR OVER BID TO MERGE, PAUSE SUITS

By Grabar Law | May 3, 2024

New York Community Bancorp Inc. shareholders traded barbs in filings this week over whether a New York federal judge should ...

GRABAR LAW OFFICE IN THE NEWS: PALO ALTO NETWORKS EXECS FACE SUIT OVER MISLEADING OUTLOOK

By Grabar Law | Apr 23, 2024

Executives and directors of cybersecurity company Palo Alto Networks have been hit with a shareholder derivative suit in California federal ...

GRABAR LAW OFFICE IN THE NEWS: SOLAREDGE HIT WITH DERIVATIVE SUIT OVER 2023 EARNINGS MISS

By Grabar Law | Mar 18, 2024

Current and former executives and directors of equipment maker SolarEdge Technologies Inc. face an investor's derivative suit in Manhattan federal ...